John S. Tregoning

8.1k total citations · 3 hit papers
116 papers, 5.7k citations indexed

About

John S. Tregoning is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, John S. Tregoning has authored 116 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Epidemiology, 46 papers in Immunology and 26 papers in Molecular Biology. Recurrent topics in John S. Tregoning's work include Respiratory viral infections research (50 papers), Influenza Virus Research Studies (32 papers) and Immune Cell Function and Interaction (20 papers). John S. Tregoning is often cited by papers focused on Respiratory viral infections research (50 papers), Influenza Virus Research Studies (32 papers) and Immune Cell Function and Interaction (20 papers). John S. Tregoning collaborates with scholars based in United Kingdom, United States and Germany. John S. Tregoning's co-authors include Jürgen Schwarze, Peter Openshaw, Sophie L. Higham, Katie E. Flight, Ziyin Wang, Benjamin F. Pierce, Ekaterina Kinnear, James A. Harker, Belinda Wang and Helen Groves and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John S. Tregoning

106 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

2021 697 citations John S. Tregoning, Katie E. Flight et al. Nature reviews. Immunology profile →
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology

2010 557 citations John S. Tregoning et al. profile →
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses

2017 365 citations Annette B. Vogel, Laura Lambert et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John S. Tregoning United Kingdom	37	2.5k	2.0k	1.8k	1.4k	929	116	5.7k
Dana G. Wolf Israel	42	3.4k 1.4×	1.9k 0.9×	1.5k 0.9×	961 0.7×	278 0.3×	159	6.6k
Taisheng Li China	40	1.5k 0.6×	5.0k 2.5×	1.3k 0.7×	944 0.7×	361 0.4×	245	8.4k
Guy A. M. Berbers Netherlands	44	4.2k 1.7×	1.3k 0.6×	1.0k 0.6×	865 0.6×	306 0.3×	204	6.6k
Fred Zepp Germany	42	2.4k 1.0×	891 0.4×	1.0k 0.6×	705 0.5×	465 0.5×	198	5.5k
Michael C. W. Chan Hong Kong	39	2.6k 1.0×	2.6k 1.3×	1.3k 0.8×	907 0.6×	655 0.7×	97	5.7k
Robert B. Couch United States	45	4.4k 1.7×	2.2k 1.1×	1.7k 1.0×	939 0.7×	338 0.4×	114	6.7k
Hadi M. Yassine Qatar	37	2.1k 0.9×	2.9k 1.4×	1.2k 0.7×	1.4k 0.9×	186 0.2×	181	6.3k
Ih‐Jen Su Taiwan	53	3.2k 1.3×	2.3k 1.1×	1.8k 1.0×	1.6k 1.1×	355 0.4×	187	9.3k
Rob Lambkin‐Williams United Kingdom	31	3.1k 1.2×	1.4k 0.7×	1.1k 0.6×	1.0k 0.7×	460 0.5×	74	4.5k
Robert F. Garry United States	43	1.9k 0.7×	3.2k 1.6×	1.3k 0.7×	1.6k 1.1×	274 0.3×	227	7.1k

Countries citing papers authored by John S. Tregoning

Since Specialization

Citations

This map shows the geographic impact of John S. Tregoning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Tregoning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Tregoning more than expected).

Fields of papers citing papers by John S. Tregoning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Tregoning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Tregoning. The network helps show where John S. Tregoning may publish in the future.

Co-authorship network of co-authors of John S. Tregoning

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Tregoning. A scholar is included among the top collaborators of John S. Tregoning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Tregoning. John S. Tregoning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peeler, David J., Rujie Sun, Ceren Kütahya, et al.. (2025). Nanoscale Biodegradable Printing for Designed Tuneability of Vaccine Delivery Kinetics. Advanced Materials. 37(15). e2417290–e2417290. 1 indexed citations

Waldock, Joanna, Rebecca Jane Cox, Othmar G. Engelhardt, et al.. (2024). Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK. Influenza and Other Respiratory Viruses. 18(10). e70013–e70013.

Chen, Kaili, Adrian Najer, Patrick Charchar, et al.. (2024). Non-invasive in vivo sensing of bacterial implant infection using catalytically-optimised gold nanocluster-loaded liposomes for urinary readout. Nature Communications. 15(1). 10321–10321. 11 indexed citations

Williams, David, John S. Tregoning, Arinder Kohli, et al.. (2024). Robust and sensitive amplicon-based whole-genome sequencing assay of respiratory syncytial virus subtype A and B. Microbiology Spectrum. 12(4). e0306723–e0306723. 2 indexed citations

Waldock, Joanna, Rebecca Jane Cox, Kanta Subbarao, et al.. (2024). Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK. Influenza and Other Respiratory Viruses. 18(11). e70014–e70014.

Wang, Ziyin, Leah Cuthbertson, Hadijatou Sallah, et al.. (2024). IL-1α is required for T cell-driven weight loss after respiratory viral infection. Mucosal Immunology. 17(2). 272–287. 4 indexed citations

Bissett, Cameron, Sandra Belij‐Rammerstorfer, Marta Ulaszewska, et al.. (2024). Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine. npj Vaccines. 9(1). 118–118. 8 indexed citations

Styles, Christine T., Jie Zhou, Katie E. Flight, et al.. (2023). Propylene glycol inactivates respiratory viruses and prevents airborne transmission. EMBO Molecular Medicine. 15(12). e17932–e17932. 5 indexed citations

McKay, Paul F., Jie Zhou, Rebecca Frise, et al.. (2022). Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets. PubMed. 3(1). iqac004–iqac004. 8 indexed citations

10.

Groves, Helen, et al.. (2021). Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity. The Journal of Experimental Medicine. 218(12). 16 indexed citations

11.

Tregoning, John S., Katie E. Flight, Sophie L. Higham, Ziyin Wang, & Benjamin F. Pierce. (2021). Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nature reviews. Immunology. 21(10). 626–636. 697 indexed citations breakdown →

12.

Tregoning, John S., E. Sherwood Brown, Hannah M. Cheeseman, et al.. (2020). Vaccines for COVID-19. Clinical & Experimental Immunology. 202(2). 162–192. 159 indexed citations

13.

Shelkovnikova, Tatyana A., et al.. (2019). Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis. Cell Reports. 29(13). 4496–4508.e4. 36 indexed citations

14.

Badamchi-Zadeh, Alexander, Kelly D. Moynihan, Rafael A. Larocca, et al.. (2018). Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy. The Journal of Immunology. 201(9). 2744–2752. 14 indexed citations

15.

Vogel, Annette B., Laura Lambert, Ekaterina Kinnear, et al.. (2017). Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses. Molecular Therapy. 26(2). 446–455. 365 indexed citations breakdown →

16.

Badamchi-Zadeh, Alexander, Paul F. McKay, Bette Korber, et al.. (2016). A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance. Frontiers in Immunology. 7. 162–162. 24 indexed citations

17.

Garnett, James P., Emma H. Baker, Jodi A. Lindsay, et al.. (2013). Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax. 68(9). 835–845. 91 indexed citations

18.

Tregoning, John S., Viviana Buffa, Anna Oszmiana, et al.. (2013). A “Prime-Pull” Vaccine Strategy Has a Modest Effect on Local and Systemic Antibody Responses to HIV gp140 in Mice. PLoS ONE. 8(11). e80559–e80559. 18 indexed citations

19.

Arias, Mauricio A., et al.. (2011). Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV‐1 gp140 vaccination in mice. European Journal of Immunology. 42(2). 353–363. 33 indexed citations

20.

Maliga, Pál, Sylvie Corneille, Kerry Ann Lutz, et al.. (2003). Tobacco chloroplasts as a platform for vaccine production.. Plant Biotechnology. 2002. 397–400.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact